KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) FCF Margin (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed FCF Margin for 7 consecutive years, with 9.39% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 1306.0% to 9.39% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.22% through Dec 2025, down 1083.0% year-over-year, with the annual reading at 12.22% for FY2025, 1083.0% down from the prior year.
  • FCF Margin hit 9.39% in Q4 2025 for GoodRx Holdings, down from 10.53% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 44.28% in Q3 2024 to a low of 1.73% in Q4 2023.
  • Historically, FCF Margin has averaged 15.88% across 5 years, with a median of 12.53% in 2021.
  • Biggest five-year swings in FCF Margin: surged 3403bps in 2024 and later tumbled -3375bps in 2025.
  • Year by year, FCF Margin stood at 11.11% in 2021, then dropped by -18bps to 9.09% in 2022, then crashed by -81bps to 1.73% in 2023, then surged by 1196bps to 22.45% in 2024, then crashed by -58bps to 9.39% in 2025.
  • Business Quant data shows FCF Margin for GDRX at 9.39% in Q4 2025, 10.53% in Q3 2025, and 24.22% in Q2 2025.